+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anal Cancer Drug"

Anal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Anal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Anal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 589 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Anal cancer drugs are a subset of colon cancer drugs, which are used to treat cancer of the rectum and anus. These drugs are typically used in combination with other treatments such as radiation therapy and surgery. Commonly used drugs include 5-fluorouracil, capecitabine, oxaliplatin, and irinotecan. These drugs work by targeting the cancer cells and preventing them from growing and spreading. The anal cancer drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are constantly developing new treatments and improving existing ones to provide better outcomes for patients. Show Less Read more